table of content
1 Study Coverage
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Introduction
1.2 Market by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Market by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts 2017-2028
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
2.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022)
2.4.2 Global Sales Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2023-2028)
2.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
2.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022)
2.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers
3.1.1 Global Top Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers by Sales (2017-2022)
3.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) in 2021
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers
3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Sales by Type (2017-2022)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Revenue by Type (2017-2022)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type
4.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022)
4.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Sales by Application (2017-2022)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Sales by Application (2023-2028)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Revenue by Application (2017-2022)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application
5.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022)
5.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
6.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
6.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
6.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
6.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
6.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
6.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
6.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
7.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
7.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
7.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
7.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
8.2.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
8.2.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
8.3.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
9.1.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
9.1.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
9.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
9.2.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
9.2.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
9.3 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
9.3.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
9.3.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
10.2.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
10.3.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Ecotrin
11.2.1 Ecotrin Corporation Information
11.2.2 Ecotrin Overview
11.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ecotrin Recent Developments
11.3 Generic
11.3.1 Generic Corporation Information
11.3.2 Generic Overview
11.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Generic Recent Developments
11.4 St. Joseph
11.4.1 St. Joseph Corporation Information
11.4.2 St. Joseph Overview
11.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 St. Joseph Recent Developments
11.5 Elanco
11.5.1 Elanco Corporation Information
11.5.2 Elanco Overview
11.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elanco Recent Developments
11.6 Zoetis
11.6.1 Zoetis Corporation Information
11.6.2 Zoetis Overview
11.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zoetis Recent Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Corporation Information
11.7.2 Boehringer Ingelheim Overview
11.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Boehringer Ingelheim Recent Developments
11.8 Merial
11.8.1 Merial Corporation Information
11.8.2 Merial Overview
11.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial Recent Developments
11.9 Merck Animal Health
11.9.1 Merck Animal Health Corporation Information
11.9.2 Merck Animal Health Overview
11.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Animal Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Analysis
12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process
12.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Marketing
12.4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels
12.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
12.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
13.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
13.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
13.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
14 Key Findings in The Global Non-steroidal Anti-inflammatory Drugs (NSAID) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
